OCGN - Ocugen - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OCGN is currently covered by 4 analysts with an average price target of $3.16. This is a potential upside of $2.23 (239.78%) from yesterday's end of day stock price of $0.93.

Ocugen's activity chart (see below) currently has 33 price targets and 42 ratings on display. The stock rating distribution of OCGN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.15% with an average time for these price targets to be met of 31 days.

Highest price target for OCGN is $2, Lowest price target is $2, average price target is $4.67.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 15-May-2024. First documented stock forecast 20-Jun-2018.

Currently out of the existing stock ratings of OCGN, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$7

$5.99 (593.07%)

1 years 9 days ago
(15-May-2024)

2/7 (28.57%)

$5.04 (257.14%)

92

Buy

$5

$3.99 (395.05%)

$5

1 years 9 days ago
(15-May-2024)

0/7 (0%)

$3.04 (155.10%)

Buy

$2

$0.99 (98.02%)

$4.5

1 years 8 months 23 days ago
(31-Aug-2023)

0/2 (0%)

$1.57 (365.12%)

Buy

$3

$1.99 (197.03%)

2 years 2 months 23 days ago
(01-Mar-2023)

0/1 (0%)

$2 (200.00%)

Buy

$11

2 years 11 months 22 days ago
(02-Jun-2022)

3/3 (100%)

$1.81 (19.70%)

80

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OCGN (Ocugen) average time for price targets to be met?

On average it took 31 days on average for the stock forecasts to be realized with a an average price target met ratio 45.15

Which analyst has the current highest performing score on OCGN (Ocugen) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on OCGN (Ocugen) with a proven track record?

JENNIFER KIM

Which analyst has the most public recommendations on OCGN (Ocugen)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 3 price targets and 5 ratings on OCGN

Which analyst is the currently most bullish on OCGN (Ocugen)?

Keay Nakae with highest potential upside - $7.6

Which analyst is the currently most reserved on OCGN (Ocugen)?

Kristen Kluska with lowest potential downside - -$0

Ocugen in the News

Ocugen Provides Business Update with First Quarter 2025 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing well and on target for potential BLA/MAA filings by mid-2026 Anticipate initiating OCU410ST Phase 2/3 pivotal confirmatory clinical trial for Stargardt disease mid- 2025 MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen...

Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results

MALVERN, Pa., May 02, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss the Company’s first quarter 2025 financial results and provide a business update at 8:30 a.m....
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?